Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)Neoplasms by Site, Skin and Connective Tissue Diseases, Thoracic Neoplasms, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, hormone receptor-positive breast cancer, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm, skin disorder, triple-negative breast carcinomaActive, not recruitingPhase 12026-09-01NCT03401385

3 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
AstraZeneca806
Daiichi Sankyo144
Daiichi Sankyo Co., Ltd.14

18 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Aichi Cancer CenterNagoyaJapan23
Dana-Farber Cancer InstituteBostonUnited States68
Johns Hopkins Sibley Memorial HospitalWashington D.C.United States3
Johns Hopkins UniversityBaltimoreUnited States150
Massachusetts General HospitalBostonUnited States1015
MD Anderson Cancer CenterHoustonUnited States589
Memorial Sloan-Kettering Cancer CenterNew YorkUnited States63
National Cancer Center HospitalChūōkuJapan28
National Cancer Center Hospital EastKashiwaJapan30
NEXT OncologySan AntonioUnited States70
Sarah Cannon Research InstituteNashvilleUnited States1
Showa Medical University HospitalShinagawa-KuJapan1
START OncologySan AntonioUnited States1
The Cancer Institute Hospital of Japanese Foundation for Cancer ResearchKoto-kuJapan16
Tisch Cancer Institute, Icahn School of MedicineNew YorkUnited States1
University of California, Los AngelesLos AngelesUnited States142
Virginia Cancer SpecialistsFairfaxUnited States109
Winship Cancer Institute of Emory UniversityAtlantaUnited States45